Showing Form 4 filings for RPRX
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Royalty Pharma Plc
Price
$68.81
Shares
257,122
Ownership
50,390
Value/Share
Coyne Terrance P.
EVP, CFO
Unknown
Industry
$57.88
4,126
23,146
Urist Marshall
EVP, Research, Investments
$58.53
100,000
293,601
Hite Christopher
EVP, COB, Partnering